DOCTOR AFTER HOURS GOLD COAST

To arrange an After Hours Doctor

55 311 224

INTERESTING MEDICAL NEWS

Passage of legislation could spell disaster for Idaho's health care system -
Mayo Clinic is forming a new permanent professorship to augment cancer research that will focus on finding new treatments and preventive measures to reduce the incidence of cancer.

Iraqi National Cancer Research Program established to curb rising incidence of breast cancer -
Liberator Medical Holdings, Inc. announces today the closing of a private placement of 4,666,667 shares of its common stock for gross proceeds of $7.0 million on March 9, 2010, to a single institutional investor. Littlebanc Advisors, LLC. acted as the sole placement agent and financial advisor to the Company. Liberator's Board of Directors unanimously approved the transaction. As part of the transaction, the institutional investor has the right to add a member of its choice to Liberator Medical's Board of Directors.

Genetic mutation in African-American men with family history of prostate cancer discovered -
"When Mitch McConnell speaks these days, he expects House Blue Dogs to be listening." The Senate minority leader is "very much part of a newly launched Republican shadow war to block health care reform by playing on the nerves of wavering Democrats across the Capitol" with "his real goal of sowing doubts about the fiscal soundness of President Barack Obama's agenda — and with it health care reform.

Lincoln, Kucinich weigh in on health bill votes -
Medical Alarm Concepts Holding, Inc., manufacturer of the MediPendant™, the only fully-monitored medical alarm system that allows you to speak and listen directly through the pendant, announces that MediPendant™ has become the first medical alarm device with Digital Enhanced Cordless Telecommunication (DECT) technology to be approved by the Federal Communications Commission.

Clinical trial shows eprotirome drug reduces blood cholesterol -
Kinetic Concepts, Inc. today announced that a United States District Court jury has found that a negative pressure wound therapy (NPWT) product marketed and sold by Smith & Nephew plc (NYSE: SNN) infringes two patents owned by Wake Forest University Health Sciences, which are exclusively licensed to KCI.